This study is in progress, not accepting new patients
A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A
Summary
- Eligibility
- for males ages 18 years and up (full criteria)
- Location
- at UC Davis UCSF
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Pfizer
- Links
- To obtain contact information for a study center near you, click here.
- ID
- NCT03061201
- Phase
- Phase 2 Hemophilia Research Study
- Study Type
- Interventional
- Participants
- About 11 people participating
- Last Updated